Serotonin Syndrome: A Real Risk of Anti-migraine Therapy

被引：0
|
作者：
Sharawat, Inder Kumar [1 ]
Panda, Prateek Kumar [1 ]
机构：
[1] All India Inst Med Sci, Dept Pediat, Pediat Neurol Unit, Rishikesh, Uttarakhand, India
来源：
INDIAN PEDIATRICS | 2020年 / 57卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：872 / 872
页数：1
相关论文
共 50 条
  • [1] Serotonin Syndrome: A Real Risk of Anti-migraine Therapy
    Inder Kumar Sharawat
    Prateek Kumar Panda
    [J]. Indian Pediatrics, 2020, 57 (9) : 872 - 872
  • [2] PHARMACODYNAMIC PRINCIPLES OF ANTI-MIGRAINE THERAPY
    FANCHAMPS, A
    [J]. HEADACHE, 1975, 15 (01): : 79 - 90
  • [3] ANTI-MIGRAINE DRUGS IN DEVELOPMENT - ADVANCES IN SEROTONIN RECEPTOR PHARMACOLOGY
    HUMPHREY, PPA
    FENIUK, W
    PERREN, MJ
    [J]. HEADACHE, 1990, 30 : 12 - 16
  • [4] Invited Commentary on Preventive Anti-Migraine Therapy (PAMT)
    Sameer Jain
    Stephen D Silberstein
    [J]. Current Treatment Options in Neurology, 2019, 21
  • [5] Invited Commentary on Preventive Anti-Migraine Therapy (PAMT)
    Jain, Sameer
    Silberstein, Stephen D.
    [J]. CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2019, 21 (04)
  • [6] Migraine therapy - Observing the risk of a serotonin syndrome in a combination of "triptanes" with anti-depressive medication
    不详
    [J]. PSYCHOPHARMAKOTHERAPIE, 2006, 13 (05): : 219 - 219
  • [7] Natural anti-migraine drugs
    Auffray-Gallet, Marine
    Rouger, Caroline
    [J]. ACTUALITES PHARMACEUTIQUES, 2024, 63 (634): : 53 - 58
  • [8] Differential medication overuse risk of novel anti-migraine therapeutics
    Saengjaroentham, Chonlawan
    Strother, Lauren C.
    Dripps, Isaac
    Jabir, Mohammad Rayhan Sultan
    Pradhan, Amynah
    Goadsby, Teeter J.
    Holland, Philip R.
    [J]. BRAIN, 2020, 143 : 2681 - 2688
  • [9] THE PHARMACOLOGY OF CURRENT ANTI-MIGRAINE DRUGS
    PEROUTKA, SJ
    [J]. HEADACHE, 1990, 30 : 5 - 11
  • [10] INTERACTION OF A POTENTIAL ANTI-MIGRAINE DRUG (ORG-GC-94) WITH THE VASOMOTOR ACTION OF SEROTONIN
    LAMAR, JC
    HARDEBO, JE
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1979, 60 (04) : 263 - 275
12345